DrugBiological

Interferon Alpha clinical trials

A group of medicines. Interferon alpha-2 (83 studies) and Interferon Alfa-n3 (5 studies) are counted on their own pages; this page counts the studies that name Interferon Alpha itself.

studies test it: 54
open now: 1
in phase 3: 14
first study started: 1990

How each study uses Interferon Alpha is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Interferon Alpha studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

recombinant interferon alfa: 17
Interferon-alpha: 10
interferon alfa: 5
interferon alpha: 5
Intron A: 4

Development codes

NSC 377523: 1

Medicines filed under Interferon Alpha

As reviewed, so not every one. Each counts its studies on its own page, not here.

Interferon alpha-2: 83
Interferon Alfa-n3: 5

Studies by the year they started

52 studies that test it; most in 1995 (6)

Studies that test Interferon Alpha, by start year
Year	Studies
1990	1
1992	1
1993	1
1994	3
1995	6
1996	4
1997	2
1999	3
2000	2
2002	3
2003	3
2004	3
2005	3
2006	2
2007	2
2008	1
2009	2
2011	1
2012	3
2013	1
2014	1
2015	1
2017	1
2020	1
2025	1

By phase

A phase 1/2 study counts in both.

Phase 1: 4
Phase 2: 30
Phase 3: 14
Phase 4: 2
No phase: 6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Melanoma: 9
Carcinoma, Renal Cell: 5
Lymphoma: 4
Hepatitis C, Chronic: 3
Pancreatic Neoplasms: 3
Hepatitis C: 3
Neoplasms: 2
Leukemia: 2
Carcinoma, Hepatocellular: 2
Multi-centric Castleman's Disease: 1
Central Nervous System Neoplasms: 1
Small Cell Lung Carcinoma: 1

Who runs them

Industry 8 · Other 46

M.D. Anderson Cancer Center (8) · National Cancer Institute (NCI) (4) · Ainos, Inc. (f/k/a Amarillo Biosciences Inc. (4) · Eastern Cooperative Oncology Group (2) · SWOG Cancer Research Network (2) · Kidney Cancer Research Bureau (2) · National Center for Research Resources (NCRR) (2) · Fudan University (2)

Often tested with

Tested in the same studies.

Etoposide (5) · Cyclophosphamide (5) · Cisplatin (5) · Vincristine (3) · Rituximab (2) · Doxorubicin (2) · Filgrastim (2) · Prednisone (2)

Related medicines

As reviewed, each with the page that says it.

One of Immunologic Factors source

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Interferon Alpha is the comparator. A study of two new drugs counts under both.

1Bomedemstat · Merck Sharp & Dohme LLC · next primary completion Jul 2027
1Ruxolitinib · University of Birmingham · next primary completion Oct 2028

Studies

Open first, then newest update. How each study uses Interferon Alpha is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 54

See all 54 studies that test Interferon Alpha →

Given beside what is tested · 24 — Interferon Alpha is usual care or a partner of the new treatment

Showing 20 of 24.

As the comparator · 7 — what is tested is compared with Interferon Alpha

Codes

What other systems call Interferon Alpha · ClinicalTrials.gg INT008551

MeSH (NLM) D016898Interferon-alphaOne source ClinicalTrials.gov

System	Code	Name there	Checked by
MeSH (NLM)	D016898	Interferon-alpha	One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.